Altres autors/es

Institut Català de la Salut

[Abellana R] Biostatistics, Department of Basic Clinical Practice, University of Barcelona, Barcelona, Spain. [Gonzalez-Loyola F] Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat de Suport a la recerca de Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. [Verdu-Rotellar JM] Unitat de Suport a la recerca de Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Gerència Atenció Primària Barcelona Ciutat, Institut Català de la Salut, Barcelona, Spain. [Bustamante A] Stroke Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain. [Palà E, Montaner J] Laboratori de Recerca Neurovascular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Clua-Espuny JL] Equip Atenció Primària, Tortosa 1-Est, Institut Català Salut, Servei Atenció Primària, UUDD Terres De l’Ebre, Tortosa, Spain

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2022-07-18T14:29:19Z

2022-07-18T14:29:19Z

2021-12



Resum

Diabetes; Hpertension; Prediction models


Diabetes; Hipertensión; Modelos de predicción


Diabetis; Hipertensió; Models de predicció


Background Several scores to identify patients at high risk of suffering atrial fibrillation have been developed. Their applicability in hypertensive diabetic patients, however, remains uncertain. Our aim is to develop and validate a diagnostic predictive model to calculate the risk of developing atrial fibrillation at five years in a hypertensive diabetic population. Methods The derivation cohort consisted of patients with both hypertension and diabetes attended in any of the 52 primary healthcare centres of Barcelona; the validation cohort came from the 11 primary healthcare centres of Terres de l’Ebre (Catalonia South) from January 2013 to December 2017. Multivariable Cox regression identified clinical risk factors associated with the development of atrial fibrillation. The overall performance, discrimination and calibration of the model were carried out. Results The derivation data set comprised 54 575 patients. The atrial fibrillation rate incidence was 15.3 per 1000 person/year. A 5-year predictive model included age, male gender, overweight, heart failure, valvular heart disease, peripheral vascular disease, chronic kidney disease, number of antihypertensive drugs, systolic and diastolic blood pressure, heart rate, thromboembolism, stroke and previous history of myocardial infarction. The discrimination of the model was good (c-index = 0.692; 95% confidence interval, 0.684-0.700), and calibration was adequate. In the validation cohort, the discrimination was lower (c-index = 0.670). Conclusions The model accurately predicts future atrial fibrillation in a population with both diabetes and hypertension. Early detection allows the prevention of possible complications arising from this disease.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Wiley

Documents relacionats

European journal of clinical investigation;51(12)

https://doi.org/10.1111/eci.13633

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)